Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-24 @ 9:58 PM
NCT ID:
NCT00038532
Eligibility Criteria:
Inclusion:
* Remain on present anti-HIV drugs during screening until a new regimen is started.
* Have a viral load of at least 1,000 copies/ml on the 2 most recent tests after at least 24 weeks of lopinavir/ritonavir and while still on it.
* Have an HIV which shows reduced susceptibility to lopinavir.
* Are at least 18 years old.
* Are not presently ill.
* Have not been treated for an opportunistic infection within 30 days of screening.
* Agree not to take certain drugs and agree to inform and get permission from the doctor before taking any medicines, over the counter medicines, herbal medicines, alcohol or recreational drugs.
* Agree to use an accepted barrier method of birth control.
Exclusion:
* Female subject is pregnant or lactating.
* Have taken any protease inhibitor other than lopinavir/ritonavir for more that two weeks.
* Are taking chemotherapy.
* Have a medical problem with their pancreas.
* Have been screened for this study within the past 12 weeks.
* Appear to be unsuitable in the opinion of the doctor.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00038532
Study Brief:
Protocol Section:
NCT00038532